Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology. Our product pipeline candidates are designed to provide differentiated drug delivery solutions that reduce the complexity and burden of the current standard of care by creating sustained release alternatives. It is our intention to develop a product portfolio to overcome the issues of patient compliance and adherence by providing means of more consistent and reliable drug dosing.


Bank Name Ocular Therapeutix, Inc.
Stock Exchange NASDAQ
Symbol OCUL
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
Chairman Dr. Amarpreet Sawhney
CEO Mr. Antony Mattessich
Employees 119
Website www.ocutx.com
Registered Year 2006